14.01.2013 Views

The use of antibiotics in traumatology and orthopaedic surgery

The use of antibiotics in traumatology and orthopaedic surgery

The use of antibiotics in traumatology and orthopaedic surgery

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

THE UUSE<br />

U OF AANTIBIOTICS<br />

A<br />

IN TTRAUMATOLOGY<br />

T<br />

AND OORTHOPAEDIC<br />

O SSURGERY<br />

S<br />

64<br />

U<br />

A<br />

T<br />

O<br />

<strong>The</strong> most common bacteria were: Staphylococcus<br />

(60.9%): S. aureus (35.8%), S. epidermidis<br />

(24.5%), Enterobacter (12.3%), Ac<strong>in</strong>etobacter<br />

(9.6%), Escherichia coli (7.2%), Klebsiella<br />

(2.4%).<br />

<strong>The</strong> bacteria isolated from the <strong>in</strong>fection sites<br />

had the follow<strong>in</strong>g antibiotic sensitivities:<br />

� Staphiloccocus aureus: Amoxiclav, Ceftriaxon,<br />

Cipr<strong>of</strong>loxac<strong>in</strong>, Vancomyc<strong>in</strong><br />

� Staphiloccocus epidermidis: Amoxiclav,<br />

Gentamyc<strong>in</strong>, Cipr<strong>of</strong>loxac<strong>in</strong>, Vancomyc<strong>in</strong><br />

� Enterobacter: Cipr<strong>of</strong>loxac<strong>in</strong>, Amikac<strong>in</strong>,<br />

Gentamyc<strong>in</strong>, Amoxiclav<br />

<strong>The</strong> antibiotic prophylaxis protocols <strong>use</strong>d<br />

<strong>in</strong> the “Bagdasar-Arseni” Orthopaedics <strong>and</strong><br />

Traumatology Cl<strong>in</strong>ic, Bucharest<br />

Surgically treated closed fractures: Ceftriaxon<br />

2g/day i.v. + Gentamyc<strong>in</strong> 80 mg/day i.v., for 1<br />

day (19).<br />

Osteotomies, open meniscectomies, surgical<br />

<strong>in</strong>terventions longer than 2 hours: Ceftriaxon<br />

2g/day i.v. + Gentamyc<strong>in</strong> 80mg/day i.v., for 1<br />

day (19).<br />

Type I <strong>and</strong> II open fractures: Ceftriaxon 2 g/<br />

day i.v. + Gentamyc<strong>in</strong> 80mg/day i.v. + ATPA<br />

+ Metronidazol 500 mg/day., for 2 days (20)<br />

REFERENCES<br />

1. Naylor PT, Myrvik QN, Webb LS –<br />

Adhesion <strong>and</strong> antibiotic resistance <strong>of</strong><br />

slime-produc<strong>in</strong>g coagulase-negative<br />

staphylococcus. Trans Orthop Res Soc<br />

1990; 15:292<br />

2. Eugenie B-B – Actualites sur les<br />

<strong>in</strong>fections a staphylocoques. Phase 5<br />

2000; ISBN 2-913544-10-X<br />

3. Drancourt M, Ste<strong>in</strong> A, Argenson JN –<br />

Oral rifamp<strong>in</strong> plus <strong>of</strong>loxac<strong>in</strong> for<br />

treatment <strong>of</strong> staphylococcus-<strong>in</strong>fected<br />

orthopedic implants. Antimicrob<br />

Agents Chemother 1993; 37:1214-1218<br />

4. Grist<strong>in</strong>a AG, Costerton JW –<br />

Bacterial adherence to biomaterials<br />

<strong>and</strong> tissue. J Bone Jo<strong>in</strong>t Surg [Am]<br />

1985; 67:264-273<br />

5. Anthony G – Biomaterial-centered<br />

<strong>in</strong>fection (Microbial Adhesion versus<br />

Mædica A Journal <strong>of</strong> Cl<strong>in</strong>ical Medic<strong>in</strong>e, Volume1 No.3 2006<br />

S<br />

Type III open fractures: Ceftriaxon 2 g/day i.v.<br />

+ Gentamyc<strong>in</strong> 80mg/day i.v. + ATPA +<br />

Metronidazol 500mg/day, for 3 days (20). �<br />

CONCLUSION<br />

<strong>The</strong> <strong>antibiotics</strong> are a very important adjuvant treatment<br />

<strong>in</strong> the ostheoarticular pathology.<br />

<strong>The</strong> antibiotic treatment cannot replace the simple<br />

surgical discipl<strong>in</strong>e <strong>and</strong> asepsis rules.<br />

<strong>The</strong> <strong>antibiotics</strong> are effective <strong>in</strong> two situations: when<br />

they are <strong>use</strong>d as prophylaxis <strong>and</strong> when the surgical cure<br />

is complete.<br />

<strong>The</strong> antibiotic treatment is not effective as long as the<br />

source <strong>of</strong> <strong>in</strong>fection (<strong>in</strong>fected implant, bone sequestrum)<br />

is not surgically removed.<br />

<strong>The</strong> antibiotic prophylaxis duration should be for one<br />

day. A longer duration <strong>of</strong> the antibiotic prophylaxis<br />

<strong>in</strong>creases the risk <strong>of</strong> microbial resistance <strong>and</strong> the cost <strong>of</strong><br />

the treatment.<br />

For the antibiotic prophylaxis one can <strong>use</strong> <strong>in</strong>ternational<br />

protocols, but our op<strong>in</strong>ion is that the antibiotic prophylaxis<br />

should be made accord<strong>in</strong>g to the specific germs <strong>of</strong> the<br />

hospital <strong>and</strong> their antibiotic sensitivity. �<br />

Tisue Integration). Cl<strong>in</strong>ical<br />

Orthopaedics <strong>and</strong> related research 2004;<br />

427:4-11<br />

6. Cordero J, Munuera L, Folgueira –<br />

Influence <strong>of</strong> metal implants on<br />

<strong>in</strong>fection. J Bone Jo<strong>in</strong>t Surg (Br) 1994;<br />

76:717-720<br />

7. Cordero J – Infection <strong>of</strong> Orthopaedic<br />

Implants – <strong>The</strong>ory <strong>and</strong> Practice. In<br />

European Instructional Course Lectures<br />

1999; 4:165-173<br />

8. Smith AH, <strong>and</strong> Swiontkowski MF –<br />

Infection after Internal Fixation <strong>of</strong><br />

Fractures. Journal <strong>of</strong> the American<br />

Academy <strong>of</strong> Orthopaedic Surgeons<br />

(JAAOS) 2000; 8:288-289<br />

9. Boxma H, Broekbwizen T, Patka P,<br />

Oost<strong>in</strong>g H – R<strong>and</strong>omized controlled<br />

trial <strong>of</strong> s<strong>in</strong>gle-dose antibiotic<br />

prophylaxis <strong>in</strong> surgical treatment <strong>of</strong><br />

closed fractures. <strong>The</strong> Dutch Trauma<br />

Trial. Lancet 1996; 347:1133-1137<br />

10. Zalavras CG, Patzakis MJ – Open<br />

Fractures: Evaluation <strong>and</strong><br />

Management, JAAOS 2003; 11:213-<br />

215<br />

11. Fitzgerald RH Jr, Rosenblatt JE,<br />

Tenney JH, Bourgault AM –<br />

Anaerobic septic arthritis. Cl<strong>in</strong> Orthop<br />

1982; 164:141<br />

12. Riss<strong>in</strong>g JP – Antimicrobial therapy<br />

for chronic osteomyelitis <strong>in</strong> adults:<br />

role <strong>of</strong> the qu<strong>in</strong>olones. Cl<strong>in</strong> Infect Dis<br />

1997; 25:1327-1333<br />

13. <strong>The</strong> Sanford Guide to Antimicrobial<br />

<strong>The</strong>rapy 2005, 35 th edition

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!